{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:27:23Z","timestamp":1790810843767,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11033-021-06439-1","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T09:17:32Z","timestamp":1622539052000},"page":"4659-4665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Melatonin and neuroblastoma: a novel therapeutic approach"],"prefix":"10.1007","volume":"48","author":[{"given":"Mohammad Hossein","family":"Pourhanifeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Mehrzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6379-5769","authenticated-orcid":false,"given":"Azam","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"9579","key":"6439_CR1","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"369","author":"JM Maris","year":"2007","unstructured":"Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet (London, England) 369(9579):2106\u20132120","journal-title":"Lancet (London, England)"},{"key":"6439_CR2","doi-asserted-by":"crossref","unstructured":"Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF et al (2015) Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol 33(27):3008\u20133017","DOI":"10.1200\/JCO.2014.59.4648"},{"issue":"8","key":"6439_CR3","first-page":"801","volume":"12","author":"L Moreno","year":"2017","unstructured":"Moreno L, Caron H, Geoerger B, Eggert A, Schleiermacher G, Brock P et al (2017) Accelerating drug development for neuroblastoma\u2014new drug development strategy: an innovative therapies for children with cancer, European network for cancer research in children and adolescents and international society of paediatric oncology Europe neuroblastoma project. Expert Opin Drug Discov 12(8):801\u2013811","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"6439_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10408363.2012.683483","volume":"49","author":"C Owens","year":"2012","unstructured":"Owens C, Irwin M (2012) Neuroblastoma: the impact of biology and cooperation leading to personalized treatments. Crit Rev Clin Lab Sci 49(3):85\u2013115","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"6439_CR5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12885-017-3493-0","volume":"17","author":"J Fischer","year":"2017","unstructured":"Fischer J, Pohl A, Volland R, Hero B, Dubbers M, Cernaianu G et al (2017) Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer 17(1):520","journal-title":"BMC Cancer"},{"issue":"2","key":"6439_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/09513590.2014.978851","volume":"31","author":"S Dragojevic Dikic","year":"2015","unstructured":"Dragojevic Dikic S, Jovanovic AM, Dikic S, Jovanovic T, Jurisic A, Dobrosavljevic A (2015) Melatonin: a \u201cHiggs boson\u201d in human reproduction. Gynecol Endocrinol 31(2):92\u2013101","journal-title":"Gynecol Endocrinol"},{"issue":"21","key":"6439_CR7","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s00018-017-2609-7","volume":"74","author":"RJ Reiter","year":"2017","unstructured":"Reiter RJ, Rosales-Corral S, Tan DX, Jou MJ, Galano A, Xu B (2017) Melatonin as a mitochondria-targeted antioxidant: one of evolution\u2019s best ideas. Cell Mol Life Sci 74(21):3863\u20133881","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"6439_CR8","first-page":"V10140568","volume":"177","author":"AG Vinther","year":"2015","unstructured":"Vinther AG, Claesson MH (2015) The influence of melatonin on the immune system and cancer. Ugeskr Laeg 177(21):V10140568","journal-title":"Ugeskr Laeg"},{"issue":"8","key":"6439_CR9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3390\/ijms19082205","volume":"19","author":"SC Bondy","year":"2018","unstructured":"Bondy SC, Campbell A (2018) Mechanisms underlying tumor suppressive properties of melatonin. Int J Mol Sci 19(8):2205","journal-title":"Int J Mol Sci"},{"issue":"Suppl","key":"6439_CR10","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","volume":"35","author":"Z Wang","year":"2015","unstructured":"Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK et al (2015) Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 35(Suppl):S224\u2013S243","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"6439_CR11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ijms18040843","volume":"18","author":"RJ Reiter","year":"2017","unstructured":"Reiter RJ, Rosales-Corral SA, Tan DX, Acuna-Castroviejo D, Qin L, Yang SF et al (2017) Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis. Int J Mol Sci 18(4):843","journal-title":"Int J Mol Sci"},{"key":"6439_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12935-019-0853-7","volume":"19","author":"MH Pourhanifeh","year":"2019","unstructured":"Pourhanifeh MH, Sharifi M, Reiter RJ, Davoodabadi A, Asemi Z (2019) Melatonin and non-small cell lung cancer: new insights into signaling pathways. Cancer Cell Int 19:131","journal-title":"Cancer Cell Int"},{"issue":"5","key":"6439_CR13","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1002\/jcp.27372","volume":"234","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Mirhosseini N, Reiter RJ, Behnamfar M, Asemi Z (2019) Melatonin and pancreatic cancer: current knowledge and future perspectives. J Cell Physiol 234(5):5372\u20135378","journal-title":"J Cell Physiol"},{"issue":"8","key":"6439_CR14","doi-asserted-by":"crossref","first-page":"12142","DOI":"10.1002\/jcp.28129","volume":"234","author":"MH Pourhanifeh","year":"2019","unstructured":"Pourhanifeh MH, Mahdavinia M, Reiter RJ, Asemi Z (2019) Potential use of melatonin in skin cancer treatment: a review of current biological evidence. J Cell Physiol 234(8):12142\u201312148","journal-title":"J Cell Physiol"},{"key":"6439_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2015.09.001","volume":"417","author":"J Vriend","year":"2015","unstructured":"Vriend J, Reiter RJ (2015) Breast cancer cells: modulation by melatonin and the ubiquitin-proteasome system\u2013a review. Mol Cell Endocrinol 417:1\u20139","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"6439_CR16","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1002\/jcp.27391","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Goradel NH, Mortezaee K, Khanlarkhani N, Najafi M, Sahebkar A (2019) Melatonin and cancer: from the promotion of genomic stability to use in cancer treatment. J Cell Physiol 234(5):5613\u20135627","journal-title":"J Cell Physiol"},{"key":"6439_CR17","doi-asserted-by":"crossref","first-page":"3510970","DOI":"10.1155\/2018\/3510970","volume":"2018","author":"R Liu","year":"2018","unstructured":"Liu R, Wang HL, Deng MJ, Wen XJ, Mo YY, Chen FM et al (2018) Melatonin inhibits reactive oxygen species-driven proliferation, epithelial-mesenchymal transition, and vasculogenic mimicry in oral cancer. Oxid Med Cell Longev 2018:3510970","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"6439_CR18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14728222.2020.1737015","volume":"24","author":"S Mehrzadi","year":"2020","unstructured":"Mehrzadi S, Hemati K, Reiter RJ, Hosseinzadeh A (2020) Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment. Expert Opin Ther Targets 24(4):359\u2013378","journal-title":"Expert Opin Ther Targets"},{"key":"6439_CR19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-med-081313-121208","volume":"66","author":"M Goldstein","year":"2015","unstructured":"Goldstein M, Kastan MB (2015) The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu Rev Med 66:129\u2013143","journal-title":"Annu Rev Med"},{"issue":"1","key":"6439_CR20","doi-asserted-by":"crossref","first-page":"e12416","DOI":"10.1111\/jpi.12416","volume":"63","author":"M Majidinia","year":"2017","unstructured":"Majidinia M, Sadeghpour A, Mehrzadi S, Reiter RJ, Khatami N, Yousefi B (2017) Melatonin: a pleiotropic molecule that modulates DNA damage response and repair pathways. J Pineal Res 63(1):e12416","journal-title":"J Pineal Res"},{"issue":"1","key":"6439_CR21","doi-asserted-by":"crossref","first-page":"a000745","DOI":"10.1101\/cshperspect.a000745","volume":"3","author":"G Giglia-Mari","year":"2011","unstructured":"Giglia-Mari G, Zotter A, Vermeulen W (2011) DNA damage response. Cold Spring Harb Perspect Biol 3(1):a000745","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"24","key":"6439_CR22","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/onc.2011.469","volume":"31","author":"R Santoro","year":"2012","unstructured":"Santoro R, Marani M, Blandino G, Muti P, Strano S (2012) Melatonin triggers p53 Ser phosphorylation and prevents DNA damage accumulation. Oncogene 31(24):2931","journal-title":"Oncogene"},{"issue":"5","key":"6439_CR23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00280-012-1828-8","volume":"69","author":"YM Wang","year":"2012","unstructured":"Wang YM, Jin BZ, Ai F, Duan CH, Lu YZ, Dong TF et al (2012) The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials. Cancer Chemother Pharmacol 69(5):1213\u20131220","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"6439_CR24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00018-003-2319-1","volume":"60","author":"RM Sainz","year":"2003","unstructured":"Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ (2003) Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci CMLS 60(7):1407\u20131426","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"6","key":"6439_CR25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12(6):401\u2013410","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"6439_CR26","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/ijms19113466","volume":"19","author":"CW Yun","year":"2018","unstructured":"Yun CW, Lee SH (2018) The roles of autophagy in cancer. Int J Mol Sci 19(11):3466","journal-title":"Int J Mol Sci"},{"issue":"20","key":"6439_CR27","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/onc.2010.630","volume":"30","author":"W van Veelen","year":"2011","unstructured":"van Veelen W, Korsse S, van de Laar L, Peppelenbosch M (2011) The long and winding road to rational treatment of cancer associated with LKB1\/AMPK\/TSC\/mTORC1 signaling. Oncogene 30(20):2289\u20132303","journal-title":"Oncogene"},{"issue":"4","key":"6439_CR28","doi-asserted-by":"crossref","first-page":"12607","DOI":"10.1111\/jpi.12607","volume":"67","author":"W Xiao","year":"2019","unstructured":"Xiao W, Xiong Z, Xiong W, Yuan C, Xiao H, Ruan H et al (2019) Melatonin\/PGC1A\/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning. J Pineal Res 67(4):12607","journal-title":"J Pineal Res"},{"issue":"1","key":"6439_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-61622-x","volume":"10","author":"A Gonz\u00e1lez-Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez A, Gonz\u00e1lez A, Rueda N, Alonso-Gonz\u00e1lez C, Men\u00e9ndez JM, Mart\u00ednez-Campa C et al (2020) Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process. Sci Rep 10(1):1\u201320","journal-title":"Sci Rep"},{"issue":"9","key":"6439_CR30","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2174\/1871520614666140812110246","volume":"14","author":"N Goncalves Ndo","year":"2014","unstructured":"Goncalves Ndo N, Rodrigues RV, Jardim-Perassi BV, Moschetta MG, Lopes JR, Colombo J et al (2014) Molecular markers of angiogenesis and metastasis in lines of oral carcinoma after treatment with melatonin. Anticancer Agents Med Chem 14(9):1302\u20131311","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"6439_CR31","first-page":"45","volume":"22","author":"P Lissoni","year":"2001","unstructured":"Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni G (2001) Anti-angiogenic activity of melatonin in advanced cancer patients. Neuroendocrinol Lett 22(1):45\u201348","journal-title":"Neuroendocrinol Lett"},{"issue":"1","key":"6439_CR32","doi-asserted-by":"crossref","first-page":"e85311","DOI":"10.1371\/journal.pone.0085311","volume":"9","author":"BV Jardim-Perassi","year":"2014","unstructured":"Jardim-Perassi BV, Arbab AS, Ferreira LC, Borin TF, Varma NR, Iskander A et al (2014) Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer. PLoS ONE 9(1):e85311","journal-title":"PLoS ONE"},{"issue":"12","key":"6439_CR33","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00595-003-2621-3","volume":"33","author":"G Soyb\u0130r","year":"2003","unstructured":"Soyb\u0130r G, Topuzlu C, Odaba\u015e \u00d6, Dolay K, B\u0130l\u0130r A, K\u00d6ksoy F (2003) The effects of melatonin on angiogenesis and wound healing. Surg Today 33(12):896\u2013901","journal-title":"Surg Today"},{"key":"6439_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-07052-3","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh MH, Dehdashtian E, Hosseinzadeh A, Sezavar SH, Mehrzadi S (2020) Clinical application of melatonin in the treatment of cardiovascular diseases: current evidence and new insights into the cardioprotective and cardiotherapeutic properties. Cardiovasc Drugs Ther. https:\/\/doi.org\/10.1007\/s10557-020-07052-3","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"6439_CR35","doi-asserted-by":"crossref","first-page":"e3336","DOI":"10.1002\/dmrr.3336","volume":"36","author":"E Dehdashtian","year":"2020","unstructured":"Dehdashtian E, Pourhanifeh MH, Hemati K, Mehrzadi S, Hosseinzadeh A (2020) Therapeutic application of nutraceuticals in diabetic nephropathy: current evidence and future implications. Diabetes\/Metab Res Rev 36(8):e3336","journal-title":"Diabetes\/Metab Res Rev"},{"key":"6439_CR36","doi-asserted-by":"crossref","first-page":"107825","DOI":"10.1016\/j.pharmthera.2021.107825","volume":"224","author":"S Mehrzadi","year":"2021","unstructured":"Mehrzadi S, Karimi MY, Fatemi A, Reiter RJ, Hosseinzadeh A (2021) SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin. Pharmacol Ther 224:107825","journal-title":"Pharmacol Ther"},{"key":"6439_CR37","doi-asserted-by":"crossref","first-page":"198108","DOI":"10.1016\/j.virusres.2020.198108","volume":"287","author":"K Bahrampour Juybari","year":"2020","unstructured":"Bahrampour Juybari K, Pourhanifeh MH, Hosseinzadeh A, Hemati K, Mehrzadi S (2020) Melatonin potentials against viral infections including COVID-19: current evidence and new findings. Virus Res 287:198108","journal-title":"Virus Res"},{"key":"6439_CR38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12935-020-01564-6","volume":"20","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh MH, Hosseinzadeh A, Juybari KB, Mehrzadi S (2020) Correction to: melatonin and urological cancers: a new therapeutic approach. Cancer Cell Int 20:466","journal-title":"Cancer Cell Int"},{"key":"6439_CR39","doi-asserted-by":"crossref","first-page":"173471","DOI":"10.1016\/j.ejphar.2020.173471","volume":"886","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh MH, Mehrzadi S, Kamali M, Hosseinzadeh A (2020) Melatonin and gastrointestinal cancers: current evidence based on underlying signaling pathways. Eur J Pharmacol 886:173471","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"6439_CR40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jpi.12205","volume":"58","author":"C Alonso-Gonz\u00e1lez","year":"2015","unstructured":"Alonso-Gonz\u00e1lez C, Gonz\u00e1lez A, Mart\u00ednez-Campa C, G\u00f3mez-Arozamena J, Cos S (2015) Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair. J Pineal Res 58(2):189\u2013197","journal-title":"J Pineal Res"},{"issue":"1","key":"6439_CR41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13046-019-1036-z","volume":"38","author":"J Hao","year":"2019","unstructured":"Hao J, Fan W, Li Y, Tang R, Tian C, Yang Q et al (2019) Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS\/hTERT signaling and cancer-stem cell traits. J Exp Clin Cancer Res 38(1):48","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"6439_CR42","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1159\/000366305","volume":"34","author":"M Yun","year":"2014","unstructured":"Yun M, Kim EO, Lee D, Kim JH, Kim J, Lee H et al (2014) Melatonin sensitizes H1975 non-small-cell lung cancer cells harboring a T790M-targeted epidermal growth factor receptor mutation to the tyrosine kinase inhibitor gefitinib. Cell Physiol Biochem 34(3):865\u2013872","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"6439_CR43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/fcp.12566","volume":"35","author":"K Hemati","year":"2021","unstructured":"Hemati K, Pourhanifeh MH, Dehdashtian E, Fatemi I, Mehrzadi S, Reiter RJ et al (2021) Melatonin and morphine: potential beneficial effects of co-use. Fundam Clin Pharmacol 35(1):25\u201339","journal-title":"Fundam Clin Pharmacol"},{"key":"6439_CR44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41413-020-0087-2","volume":"8","author":"F Chen","year":"2020","unstructured":"Chen F, Jiang G, Liu H, Li Z, Pei Y, Wang H et al (2020) Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1\u03b2\/NF-\u03baB-NLRP3 inflammasome positive feedback loop. Bone Res 8:10","journal-title":"Bone Res"},{"issue":"8","key":"6439_CR45","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/biom10081158","volume":"10","author":"D Chen","year":"2020","unstructured":"Chen D, Zhang T, Lee TH (2020) Cellular mechanisms of melatonin: insight from neurodegenerative diseases. Biomolecules 10(8):1158","journal-title":"Biomolecules"},{"key":"6439_CR46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuroscience.2019.09.009","volume":"429","author":"CH Liu","year":"2020","unstructured":"Liu CH, Chang HM, Yang YS, Lin YT, Ho YJ, Tseng TJ et al (2020) Melatonin promotes nerve regeneration following end-to-side neurorrhaphy by accelerating cytoskeletal remodeling via the melatonin receptor-dependent pathway. Neuroscience 429:282\u2013292","journal-title":"Neuroscience"},{"issue":"2","key":"6439_CR47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0304-3940(96)13035-4","volume":"216","author":"S Cos","year":"1996","unstructured":"Cos S, Verduga R, Fern\u00e1ndez-Viadero C, Meg\u00edas M, Crespo D (1996) Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci Lett 216(2):113\u2013116","journal-title":"Neurosci Lett"},{"issue":"10","key":"6439_CR48","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1002\/cam4.2389","volume":"8","author":"WJ Lee","year":"2019","unstructured":"Lee WJ, Chen LC, Lin JH, Cheng TC, Kuo CC, Wu CH et al (2019) Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy. Cancer Med 8(10):4821\u20134835","journal-title":"Cancer Med"},{"key":"6439_CR49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mce.2015.01.003","volume":"402","author":"Y Pan","year":"2015","unstructured":"Pan Y, Niles LP (2015) Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells. Mol Cell Endocrinol 402:57\u201363","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"6439_CR50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1134\/S1819712417010044","volume":"11","author":"O Krestinina","year":"2017","unstructured":"Krestinina O, Myakisheva S, Baburina YL, Fadeev R, Azarashvili T, Akatov V (2017) The effects of isoquinoline carboxamide and melatonin on the differentiation of N1E\u2013115 mouse neuroblastoma cells (clone C-1300) and on the expression of the TSPO translocation protein and 2\u2019, 3\u2019-cyclonucleotide-3\u2019-phosphodiesterase in these cells. Neurochem J 11(1):31\u201337","journal-title":"Neurochem J"},{"issue":"3","key":"6439_CR51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3340\/jkns.2015.57.3.147","volume":"57","author":"M Tosun","year":"2015","unstructured":"Tosun M, Soysal Y, Mas NG, Karabekir HS (2015) Comparison of the effects of 13-cis retinoic acid and melatonin on the viabilities of SH-SY5Y neuroblastoma cell line. J Korean Neurosurg Soc 57(3):147\u2013151","journal-title":"J Korean Neurosurg Soc"},{"issue":"1","key":"6439_CR52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-079X.2007.00548.x","volume":"45","author":"JG Pizarro","year":"2008","unstructured":"Pizarro JG, Yeste-Velasco M, Esparza JL, Verdaguer E, Pallas M, Camins A et al (2008) The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. J Pineal Res 45(1):8\u201316","journal-title":"J Pineal Res"},{"issue":"2","key":"6439_CR53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-079X.2006.00342.x","volume":"41","author":"G Garcia-Santos","year":"2006","unstructured":"Garcia-Santos G, Antolin I, Herrera F, Martin V, Rodriguez-Blanco J, del Pilar CM et al (2006) Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 41(2):130\u2013135","journal-title":"J Pineal Res"},{"issue":"5","key":"6439_CR54","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/1567205017666200624201356","volume":"17","author":"M Shukla","year":"2020","unstructured":"Shukla M, Chinchalongporn V, Govitrapong P (2020) Melatonin prevents neddylation dysfunction in A\u03b242-Exposed SH-SY5Y neuroblastoma cells by regulating the amyloid precursor protein- binding protein 1 pathway. Curr Alzheimer Res 17(5):446\u2013459","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"6439_CR55","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.3390\/cancers12092343","volume":"12","author":"D Cangelosi","year":"2020","unstructured":"Cangelosi D, Morini M, Zanardi N, Sementa AR, Muselli M, Conte M et al (2020) Hypoxia predicts poor prognosis in neuroblastoma patients and associates with biological mechanisms involved in telomerase activation and tumor microenvironment reprogramming. Cancers 12(9):2343","journal-title":"Cancers"},{"issue":"12","key":"6439_CR56","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.3390\/ijms19124114","volume":"19","author":"SH Kim","year":"2018","unstructured":"Kim SH, Kwon DY, Kwak JH, Lee S, Lee YH, Yun J et al (2018) Tunicamycin-induced ER stress is accompanied with oxidative stress via abrogation of sulfur amino acids metabolism in the liver. Int J Mol Sci 19(12):4114","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6439_CR57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12192-019-00994-0","volume":"24","author":"J Xing","year":"2019","unstructured":"Xing J, Xu H, Liu C, Wei Z, Wang Z, Zhao L et al (2019) Melatonin ameliorates endoplasmic reticulum stress in N2a neuroblastoma cell hypoxia-reoxygenation injury by activating the AMPK-Pak2 pathway. Cell Stress Chaperones 24(3):621\u2013633","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"6439_CR58","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3892\/or.2017.5446","volume":"37","author":"A Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez A, Gonz\u00e1lez-Gonz\u00e1lez A, Alonso-Gonz\u00e1lez C, Men\u00e9ndez-Men\u00e9ndez J, Mart\u00ednez-Campa C, Cos S (2017) Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF. Oncol Rep 37(4):2433\u20132440","journal-title":"Oncol Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06439-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T23:20:39Z","timestamp":1725146439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06439-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["6439"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06439-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}